Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:310 (5 August), doi:10.1136/bmj.333.7562.310
Christmas is coming and the goose is getting fat. Even though there are still five months to go, we like to have lots of time to prepare here at the BMJ. So we would be grateful if you would submit any papers and articles destined for the Christmas issue of the BMJ to http://submit.bmj.com by no later than the end of September.
An NHS psychiatrist hoping to make some extra cash to pay for a masters degree course has opted to try his hand on eBay, the online auction site. For a starting price of just £25, eBay customers can bid to email him five questions on their chosen mental health topic. He also has other things for sale, and has sold about 400 items. No one has yet taken him up on his clinical skills (Guardian 19 July 2006).
A randomised controlled trial recently showed that male circumcision could reduce the sexual transmission of HIV from women to men by around 60%. Researchers have now used mathematical models to estimate the potential impact on health of circumcising all men in sub-Saharan Africa. The models predict that male circumcision could prevent two million new cases of HIV infection over the next decade and reduce deaths by 300 000. If extended for another 10 years, 3.7 million additional infections and 2.7 million deaths could be prevented. They argue that male circumcision is equivalent to an intervention that reduces transmission in both directions (between men and women) by 37% (PLoS Medicine 2006;3: e262).
Multitasking may be the only way to cope with the demands of the modern world, but a new functional magnetic resonance imaging study (Proceedings of the National Academy of Sciences U S A 2006;103: 11778-83
In young babies, suprapubic aspiration to obtain a urine sample causes more pain than urethral catheterisation (Pediatrics 2006;118: e51-6
Volunteers for HIV vaccine research may be at greater risk of HIV infection than the general population. Specifically, they are more likely not to use condoms and to have had a sexually transmitted disease. Phase III vaccine trials seek participants who are at high risk of HIV. However, phase I vaccine trials need healthy people who are at low risk, so the risk profile of participants should be taken into account when recruiting for such trials. Tighter inclusion criteria might be needed to avoid risk of infection (AIDS Care 2006;18: 569-73[CrossRef][Medline]).
Guidelines from the UK's Driver and Vehicle Licensing Agency came under scrutiny by several psychiatrists who specialise in old age. Although more than half (32 of 57) of the psychiatrists were satisfied with the eventual decision about whether people with dementia should be allowed to drive, they were critical of two of the existing factors taken into account in the assessment of driving ability. These were the mini mental state examination and the patients' own reports of their driving ability (Psychiatric Bulletin 2006;30: 265-8
Giving vitamin A supplements to mothers and babies in Zimbabwe to prevent anaemia proved fruitless even though vitamin A deficiency is a recognised cause of neonatal anaemia. A randomised controlled study of 1592 babies observed from 8 to 14 months of age showed that although HIV infection and low concentrations of iron at birth independently increased the risk of anaemia, vitamin A supplements made no difference to the haemoglobin count or anaemia (American Journal of Clinical Nutrition 2006; 84: 212-22
A recent study in Neurology (2006;67: 33-8
Just when there seemed to be hope of a drug treatment for chronic fatigue syndrome, the evidence falls flat. Previous research suggested that natural killer cell activity is reduced in patients with this syndrome. But a randomised, double blind, placebo controlled trial of BioBran MGN-3, a substance that enhances natural killer cell activity, taken for eight weeks, made no significant difference. Interestingly though, the fatigue measures of all 64 patients (whether taking placebo or BioBran MGN-3) improved over time (Quarterly Journal of Medicine 2006;99: 461-8
|
Minerva was amused by a brave statement made in the Journal of Thoracic and Cardiovascular Surgery (2006;132: 5-7
If you want to know what patients think, ask them. A qualitative study of patients' experiences found that even short consultations for psychological issues can be very effective, at least in the short term (British Journal of General Practice 2006;56: 496-503). Don't underestimate the power of providing a safe place where patients feel listened to and understood.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+